Obsessive-Compulsive Disorder: Clinical Trials

5 trials for Obsessive-Compulsive Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Obsessive-Compulsive Disorder: new trials by email Literature Review of Obsessive-Compulsive Disorder trials Research Report on Obsessive-Compulsive Disorder

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
IVIG - Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
Phase 4UnknownIMMUNOe Research Centers212017-11-242019-11-19
Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)
Luvox CR, Behavioral Therapy - Obsessive Compulsive Disorder
Phase 4UnknownRogers Center for Research & Training, Inc.502008-09-012008-09-04
Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder
Active DBS, Sham DBS - Obsessive-Compulsive Disorder
Phase 4UnknownButler Hospital272008-03-012024-07-29
Methylphenidate in ADHD With Trichotillomania
Methylphenidate - ADHD, Trichotillomania
Phase 4UnknownGeha Mental Health Center302007-10-012007-11-01
Treatment Youth With Obsessive-Compulsive Disorder
Escitalopram - Obsessive Compulsive Disorder
Phase 4UnknownUniversity of Ottawa402007-01-012008-07-02

Narrower conditions

Anxiety Disorders (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (1)  ·  Pediatric acute-onset neuropsychiatric syndrome (1)  ·  Trichotillomania (1)

Broader conditions

Mental Disorders (5)  ·  Anxiety Disorders (4)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Neurodevelopmental Disorders (1)

Interventions

Behavior Therapy (1)  ·  Dexetimide (1)  ·  Escitalopram (1)  ·  Fluvoxamine (1)  ·  Immunoglobulins, Intravenous (1)  ·  Implantable Neurostimulators (1)  ·  Methylphenidate (1)

Sponsors

Butler Hospital (1)  ·  Geha Mental Health Center (1)  ·  IMMUNOe Research Centers (1)  ·  Rogers Center for Research & Training, Inc. (1)  ·  University of Ottawa (1)

Countries

United States (3)  ·  Canada (1)  ·  Israel (1)

Top investigators

Benjamin D. Greenberg, MD, PhD (1)  ·  Isaac Melamed, MD (1)  ·  John H Greist, MD (1)  ·  Martine F. Flament, MD (1)  ·  Pavel Golubchik, M.D. (1)

Results publications

PMID 13638508, PMID 14399272, PMID 21586916, PMID 23128051, PMID 2684084, PMID 33601937, PMID 444788, PMID 8290681

NIH funding

U01MH076179 (1)